Table I.
Group | Rolofylline dose (mg) | Number of subjects analyzed |
---|---|---|
1 | 1.0 | 5 |
2.5 | 4a | |
2 | 2.5 | 8 |
5.0 | 6 | |
10 | 6 | |
3 | 20 | 6 |
30 | 6 | |
4 | 40 | 5 |
50 | 6 | |
60 | 6 |
aOne subject received less than 1/10 of the 2.5-mg dose
Group | Rolofylline dose (mg) | Number of subjects analyzed |
---|---|---|
1 | 1.0 | 5 |
2.5 | 4a | |
2 | 2.5 | 8 |
5.0 | 6 | |
10 | 6 | |
3 | 20 | 6 |
30 | 6 | |
4 | 40 | 5 |
50 | 6 | |
60 | 6 |
aOne subject received less than 1/10 of the 2.5-mg dose